On September 3, LENS fell 3.04% in regular trading, trading at HK$23.62 with turnover of approximately HK$71.95 million, extending the downward adjustment since the release of its interim results.

On the earnings front, the company reported H1 revenue of RMB 28.87 billion, down 12.42% year-over-year, with net profit attributable to shareholders falling 49.52% to RMB 577 million. Adjusted net profit plunged 70.45% to just RMB 278 million. The core smartphone and PC segment, accounting for over 77% of revenue, saw a 17.67% year-over-year decline, serving as the primary drag on performance. Meanwhile, asset impairment provisions of RMB 456 million further pressured profitability. On the A-share side, major institutional funds continued to record net outflows, amplifying market divergence over valuation sustainability.

Notably, CLSA recently raised its target price to HK$30.7 maintaining an outperform rating, while Bank of America reiterated a buy rating with a HK$27 target, citing Q2 profit recovery and business diversification. UBS also increased its long position in LENS H-shares to 11.42%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)